BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34668612)

  • 1. Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5.
    Li M; Shen Y; Xiong Y; Wang S; Li C; Bai J; Zhang Y
    Cell Prolif; 2021 Dec; 54(12):e13136. PubMed ID: 34668612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy.
    Yang J; Rao S; Cao R; Xiao S; Cui X; Ye L
    Aging (Albany NY); 2021 Jul; 13(13):17462-17472. PubMed ID: 34253689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy.
    Wang J; Qi Q; Zhou W; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Jiang Z; Bjerkvig R; Prestegarden L; Thorsen F; Wang X; Li X; Wang J
    Autophagy; 2018; 14(11):2007-2022. PubMed ID: 30025493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression.
    Walhart TA; Vacca B; Hepperla AJ; Hamad SH; Petrongelli J; Wang Y; McKean EL; Moksa M; Cao Q; Yip S; Hirst M; Weissman BE
    Am J Pathol; 2023 Apr; 193(4):456-473. PubMed ID: 36657718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5.
    Cheng X; Xu Q; Zhang Y; Shen M; Zhang S; Mao F; Li B; Yan X; Shi Z; Wang L; Sheng G; Zhang Q
    Eur J Pharmacol; 2019 May; 850():53-63. PubMed ID: 30716314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
    Hong SH; Son KH; Ha SY; Wee TI; Choi SK; Won JE; Han HD; Ro Y; Park YM; Eun JW; Nam SW; Han JW; Kang K; You JS
    Cancer Res; 2021 Jan; 81(2):356-370. PubMed ID: 33239431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
    Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
    Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy.
    Gounder MM; Zhu G; Roshal L; Lis E; Daigle SR; Blakemore SJ; Michaud NR; Hameed M; Hollmann TJ
    Clin Cancer Res; 2019 Apr; 25(7):2064-2071. PubMed ID: 30642912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
    Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
    Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.
    Radko-Juettner S; Yue H; Myers JA; Carter RD; Robertson AN; Mittal P; Zhu Z; Hansen BS; Donovan KA; Hunkeler M; Rosikiewicz W; Wu Z; McReynolds MG; Roy Burman SS; Schmoker AM; Mageed N; Brown SA; Mobley RJ; Partridge JF; Stewart EA; Pruett-Miller SM; Nabet B; Peng J; Gray NS; Fischer ES; Roberts CWM
    Nature; 2024 Apr; 628(8007):442-449. PubMed ID: 38538798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.
    Owosho AA; Zhang L; Rosenblum MK; Antonescu CR
    Genes Chromosomes Cancer; 2018 Feb; 57(2):89-95. PubMed ID: 29119645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ATG5-dependent macroautophagy by chaperone-mediated autophagy promotes breast cancer cell metastasis.
    Han Q; Deng Y; Chen S; Chen R; Yang M; Zhang Z; Sun X; Wang W; He Y; Wang F; Pan X; Li P; Lai W; Luo H; Huang P; Guan X; Deng Y; Yan J; Xu X; Wen Y; Chen A; Hu C; Li X; Li S
    Sci Rep; 2017 Jul; 7(1):4759. PubMed ID: 28684853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma.
    Wang CZ; Yan GX; Dong DS; Xin H; Liu ZY
    World J Gastroenterol; 2019 Sep; 25(35):5310-5322. PubMed ID: 31558875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningeal SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily B member 1 (SMARCB1)-deficient tumours: an emerging group of meningeal tumours.
    Dadone B; Fontaine D; Mondot L; Cristofari G; Jouvet A; Godfraind C; Varlet P; Ranchère-Vince D; Coindre JM; Gastaud L; Baudoin C; Peyron AC; Thyss A; Coutts M; Michiels JF; Pedeutour F; Burel-Vandenbos F;
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):433-449. PubMed ID: 27732747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
    Darr J; Klochendler A; Isaac S; Eden A
    Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
    Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
    Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.